Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Respiratory Syncytial Virus Attachment Glycoprotein G Subtype B (RSV G Subtype B)
- Target
- RSV G Subtype B
- Molecular classification
- Type II transmembrane glycoprotein, Attachment protein
01
Overview
The respiratory syncytial virus (RSV) attachment glycoprotein G subtype B is a major surface protein responsible for mediating the initial attachment of RSV subgroup B viruses to host cells. It is a type II transmembrane glycoprotein with a highly variable ectodomain. It acts as a neutralizing antigen and is considered a potential target for vaccine development. While not essential for infectivity (unlike F protein), its high variability allows it to evade immune detection more effectively. It exists in both membrane-bound and secreted forms; the secreted form can modulate immune responses.
- Other names
- RSV G protein Subtype BRSV-B G glycoproteinRSV attachment protein G Subtype B
02
Mechanism of action
Viral attachment inhibition (potential)
03
Biological functions
Viral attachmentImmunomodulationHost cell entry
04
Disease associations
InfectionRespiratory Syncytial Virus InfectionBronchiolitisPneumonia
05
Safety considerations
High genetic variability may limit therapeutic efficacyPotential for immune evasionPotential for off-target effects due to glycosylation
Beyond the preview
Go deeper on Respiratory Syncytial Virus Attachment Glycoprotein G Subtype B (RSV G Subtype B).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Respiratory Syncytial Virus Attachment Glycoprotein G Subtype B (RSV G Subtype B).